
GLP-1 weight loss in Louisiana
- Visit type
- One video visit to start
- Licensing
- Louisiana State Board of Medical Examiners
- Updated
- Licensed by
- Louisiana State Board of Medical Examiners
- Telehealth
- One video visit to start
- Semaglutide injections
- Available
- Tirzepatide injections
- Available
- Medicaid
- Limited coverage
- Shipping
- 2–3 business days
Louisiana residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from New Orleans and Baton Rouge to Shreveport, Lafayette, and the rural parishes in between. Pallas Health pairs you with a board-certified provider licensed in Louisiana who evaluates your eligibility on a live video visit, scheduled right after your intake, and, if appropriate, sends a prescription to a US-licensed pharmacy that ships to any Louisiana address in 2–3 business days. Compounded semaglutide is $139 first month, then $199 every 4 weeks; compounded tirzepatide is $179 first month, then $299 every 4 weeks.
How telehealth prescribing works in Louisiana
Louisiana patients complete one live video visit with a Louisiana-licensed clinician before any prescription is issued. Louisiana's physician telemedicine statute defines telemedicine as real-time, two-way audio and video, and Pallas's clinical network treats Louisiana as a video-visit state. Ongoing care after that visit is handled by secure message.
Louisiana requires any provider prescribing to a Louisiana resident to hold an active Louisiana medical license or telemedicine permit. Louisiana's physician telemedicine statute (La. R.S. 37:1262) defines telemedicine as health care delivered through interactive technology that lets the provider and the patient interact by two-way video and audio at the same time, and the Louisiana State Board of Medical Examiners' telemedicine rules hold that encounter to the same standard of care as an in-person visit. Pallas's clinical network treats Louisiana as a video-visit state: every Pallas clinician who treats Louisiana patients holds an active Louisiana license and conducts a live video visit with the patient before any prescription is issued. Once that visit establishes the relationship, ongoing check-ins and dose adjustments are handled by secure message. GLP-1s are not controlled substances, so Louisiana's separate controlled-substance telemedicine requirements do not apply — but our providers still take a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and follow up after initiation to monitor response and titrate the dose.
Medicaid & insurance in Louisiana
Louisiana Medicaid (Healthy Louisiana) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited, and compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Simple cash-pay pricing in Louisiana
No insurance, and the same price in every Louisiana ZIP code. You see your full price during intake, before you pay anything. One plan price covers your US-licensed provider, check-ins, dose adjustments and care-team messaging, with no membership fee. Medication ships free, and nothing is charged until a clinician prescribes. Cancel anytime. Your clinician helps determine which option is appropriate for you.
Compounded
- Semaglutide injectionsFrom $139
- Tirzepatide injectionsFrom $179
Brand-name
- Wegovy® injectionsFrom $499
- Zepbound® injectionsFrom $499
- Ozempic® injectionsFrom $499
- Mounjaro® injections$1,099/mo
- Wegovy® pillFrom $299
- Foundayo™ pillFrom $299
Semaglutide and tirzepatide prices in Louisiana, plan by plan
Semaglutide vs tirzepatide in Louisiana
Both are once-weekly injections available to Louisiana patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.
In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks — with broadly similar tolerability. That trial predates Wegovy®'s higher 7.2 mg weekly dose, which reached 18.7% average weight loss over 72 weeks in the separate STEP UP trial; separate trials do not provide a direct comparison. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Cost and track record differ too: compounded semaglutide renews at $199 every 4 weeks versus $299 for tirzepatide (full terms in the questions below), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Louisiana — our full semaglutide vs tirzepatide comparison covers the deeper differences.
Cash-pay GLP-1 telehealth compared for Louisiana
Pallas is a cash-pay telehealth service that serves every ZIP code in Louisiana. Compounded semaglutide is one all-in plan price: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That price covers your US-licensed clinician, ongoing check-ins and the medication when prescribed, with no separate membership fee. Louisiana requires one live video visit, which is included in the plan.
| Service | Published price | Medication | Charged at signup |
|---|---|---|---|
| Pallas Health | $139 first month, then $199 every 4 weeks; no membership fee | Included, with your US-licensed clinician, check-ins and messaging | Nothing until a clinician prescribes |
| Ro | $149/mo membership month-to-month; $39 first month; $74/mo on a 12-month prepay | Billed separately. Brand-name only on its pricing page (Wegovy® pen from $199/mo); no compounded semaglutide price published | $39, refunded if not eligible |
| Henry Meds | From $179/mo, varies by medication and dose | Included, with provider visits and supplies | Not stated on its pricing page |
| Mochi Health | $79/mo membership; $39 first month | Billed separately. Compounded semaglutide from $60/mo, compounded tirzepatide from $90/mo | $39 due today |
Other services’ figures are quoted from their own websites on September 24, 2026; prices change often and vary by dose and plan length, and availability in Louisiana varies by service. Hims & Hers is not listed because no current published price could be verified on that date. This is a factual comparison, not a ranking or an endorsement.
Four things to check before you pay any GLP-1 telehealth service
- Does the quoted price include the medication, or is it a membership billed on top of it?
- Is the company LegitScript-certified? Any website can be checked at legitscript.com.
- Are you charged before a clinician has reviewed you and prescribed?
- Does the clinician hold a Louisiana license, and does the pharmacy filling the prescription hold a Louisiana permit?
Cities served in Louisiana
Partner pharmacies ship to every ZIP code in Louisiana, including:
- New Orleans
- Baton Rouge
- Shreveport
- Lafayette
- Lake Charles
- Kenner
- Bossier City
- Metairie
Prescription GLP-1s
Doctor-led GLP-1 weight loss care, shipped by a US-licensed pharmacy.
From $139/mo
Before
AfterLouisiana GLP-1 questions
Start the online intake (about 5 minutes), then have one video visit with a Louisiana-licensed clinician. If a GLP-1 is appropriate, a US-licensed pharmacy ships it to you in 2–3 business days.
Same intake as semaglutide. If appropriate, a Louisiana-licensed clinician can prescribe compounded tirzepatide or FDA-approved Zepbound® or Mounjaro®, and explains which fits you.
Yes. A Louisiana-licensed clinician can prescribe it for you with a documented clinical reason, and a US-licensed compounding pharmacy prepares it per patient. Brand-name Wegovy® is also available.
Yes. Louisiana nurse practitioners prescribe under a collaborative practice agreement with a physician. GLP-1s are not controlled substances, so they can be prescribed after one video visit.
Several do. Check that its clinicians are licensed in Louisiana, that it uses US-licensed compounding pharmacies, and that it is LegitScript-certified. Pallas serves Louisiana.
Yes, one. Louisiana requires a live video visit to start care. It is included in your plan and scheduled after intake; follow-ups happen by secure message.
Intake takes about 5 minutes, and your video visit with a Louisiana-licensed clinician is usually within 1 to 2 business days. If prescribed, the pharmacy ships in 2–3 business days.
Yes. Partner pharmacies ship to every Louisiana ZIP code, from New Orleans and Baton Rouge to the smallest towns, usually in 2–3 business days. Remote addresses may take an extra day.
Several do. Check that its clinicians hold a Louisiana license, that it uses US-licensed pharmacies, and that it is LegitScript-certified (the database is public). Pallas serves Louisiana.
Louisiana Medicaid (Healthy Louisiana) covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
One flat cash-pay price, the same in every Louisiana ZIP code, no insurance needed. It covers your clinician, check-ins and messaging, and medication ships free once prescribed.
A Louisiana-licensed clinician decides after your intake and video visit. GLP-1s are generally considered at a BMI of 30 or more, or 27 or more with a condition like high blood pressure.
Wegovy®, Ozempic®, Zepbound® and Mounjaro® are FDA-approved. Compounded semaglutide and tirzepatide are made per patient by US-licensed pharmacies and are not FDA-approved. Your clinician decides.
Yes. Tell your clinician your current medication, dose and everything else you take during intake. If appropriate, they continue you at a comparable dose. Don't change a prescription on your own.
Most patients use a once-weekly injection with a very fine needle. A daily tablet is available on request. Your clinician confirms which form is appropriate for you.
Mostly stomach-related: nausea, constipation or diarrhea, usually mildest when the dose is raised slowly. They are avoided in pregnancy and with a personal or family history of medullary thyroid cancer or MEN2.
You answer health questions online in about 5 minutes, then meet a Louisiana-licensed clinician by video. If a GLP-1 is appropriate, a licensed pharmacy ships it in 2–3 business days.
Your first order arrives in 2–3 business days, and most patients start low and step up gradually. Your plan renews on a set schedule so refills arrive before you run out; change or cancel anytime in the portal.
Compounded semaglutide injections are $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Compounded tirzepatide injections are $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Yes. Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight management, Ozempic® and Mounjaro® for type 2 diabetes. All are cash-pay: pens from $499 first month, daily pills from $299.
Louisiana Medicaid (Healthy Louisiana) covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
Two cash-pay paths: stay on Wegovy® or Zepbound® from $499 first month, or a compounded plan from $139 first month if a licensed clinician finds it appropriate. Tell your clinician your current dose.
A decision for you and your clinician. Semaglutide costs less and has the longer track record; tirzepatide acts on two gut-hormone receptors instead of one. The comparison above covers the trials.
Pallas serves all of Louisiana with one price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. One video visit is included.
More states
Rule changes affecting Louisiana
- 2026-11-09 Louisiana moved to video-visit-required; Washington D.C., North Dakota, New Mexico, and South Dakota moved to async-eligible. The video-required list now stands at 5 states (Arkansas, Louisiana, Mississippi, Rhode Island, and West Virginia); the District is no longer on it.Confirmed with our clinical network's licensing and routing team on 2026-11-06, after its medical group changed on 2026-10-31.
From our state-by-state rules tracker. Get an email when a rule changes.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.







